List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 263 studies with search of: herpes
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease
Condition: Prophylaxis Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine- adjuvanted GSK208141;   Biological: Placebo injection
2 Completed Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects
Condition: Prophylaxis for Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine- adjuvanted GSK 208141;   Biological: Placebo
3 Recruiting A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis
Conditions: Herpes Labialis;   Herpes Simplex Virus
Interventions: Drug: Glutamine;   Drug: Glycine
4 Completed A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding
Condition: Genital Herpes
Intervention: Drug: Famciclovir
5 Completed A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients
Condition: Genital Herpes
Intervention: Drug: valaciclovir (Valtrex)
6 Completed Efficacy and Safety of Famciclovir 1-Day Treatment Compared to 3-Day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes
Condition: Genital Herpes
Interventions: Drug: Famciclovir;   Drug: Valacyclovir
7 Completed Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant
Condition: Prophylaxis Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine GSK208141 - non-MPL-containing adjuvant;   Biological: Herpes simplex candidate vaccine GSK208141- MPL-containing adjuvant
8 Completed Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines
Condition: Prophylaxis Herpes Simplex
Interventions: Biological: Adjuvanted herpes simplex (gD) candidate vaccine GSK 208141;   Biological: Herpes simplex virus containing gD-Alum
9 Completed Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes
Condition: Recurrent Genital Herpes
Intervention: Drug: Famciclovir
10 Recruiting Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A
Condition: Herpes Zoster in Autologous Hematopoietic Stem Cell Transplantation Recipients
Interventions: Biological: Herpes Zoster Vaccine 1437173A;   Biological: Placebo vaccine (saline)
11 Recruiting A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster
Conditions: Herpes Zoster;   Shingles
Interventions: Drug: valacyclovir;   Drug: FV-100;   Drug: Valacyclovir placebo;   Drug: FV-100 placebo
12 Completed A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
Condition: Herpes Genitalis
Interventions: Drug: ASP2151;   Drug: valacyclovir;   Drug: Placebo
13 Completed Activation of Alternative Cellular Energy (ACE) Pathway in the Therapy of Herpes Virus Infections
Conditions: Herpes Simplex;   Herpes Zoster
Intervention:
14 Completed Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates
Condition: Herpes Simplex
Interventions: Drug: Acyclovir;   Drug: Placebo
15 Active, not recruiting Patient-Initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients
Condition: Genital Herpes
Interventions: Drug: Famciclovir;   Drug: Placebo
16 Completed Efficacy of Acyclovir in Combination With a Glucocorticosteroid on UV-Induced Herpes Labialis
Condition: Herpes Labialis
Interventions: Drug: ME-609;   Drug: Vehicle
17 Recruiting Acupuncture in Herpes Zoster Neuralgia (ACUZoster)
Conditions: Herpes Zoster;   Postherpetic Neuralgia;   Pain
Interventions: Device: Sham-laser acupuncture;   Drug: gabapentine;   Procedure: Acupuncture
18 Completed Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old
Condition: Herpes Simplex
Interventions: Biological: GSK208141;   Biological: Placebo;   Biological: HavrixTM (investigational formulation)
19 Completed Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding
Conditions: Herpes Genitalis;   HIV Infection
Intervention: Drug: Valacyclovir
20 Completed Dose-Finding Study of ASP2151 in Subjects With Herpes Zoster
Condition: Herpes Zoster
Interventions: Drug: ASP2151;   Drug: Valacyclovir hydrochloride

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services